The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030.
The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.
Related resources
-
WHO progress report on HIV, viral hepatitis and STIs 2019
Rest of World Reports & Research, Strategy & Planning PDF -
WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.UK, Rest of World Reports & Research, Tools & Templates, Strategy & Planning PDF -
Hepatitis C in England 2019 report
Public Health England's annual report on the UK’s progress towards eliminating hepatitis C sets out that although a lot has been achieved towards the World Health Organisation’s target of eliminating hepatitis C as a major public health threat by 2030, there is still much to do. In particular, the report calls for a 'radical change' in the health service's approach to hepatitis C among people who inject drugs.UK 09 Apr 2019 Reports & Research, Strategy & Planning PDF -
Hepatitis C Annual Epidemiological Report for 2017
The European Centre for Disease Prevention and Control has published a new report on the prevalence of hepatitis C in Europe. The report indicates a 10% decrease in newly reported hepatitis C cases from 2016 to 2017, but also warns of the under-reporting of diagnosed cases and the variation of national testing practices impacting the reliability of this statistic. Headline figures show that 5.6 million Europeans live with chronic hepatitis C, with more than 31,000 recorded cases in 2017.Rest of World Reports & Research PDF -
Evalution of injecting equipment providing services in NHS Tayside
The Scottish Drugs Forum and Hepatitis Scotland carried out an evaluation of the effectiveness of injecting equipment providing services, noting barriers and recommendations to Tayside NHS. The report includes information on the provision of hepatitis C testing at injecting equipment providing services.UK, Scotland Reports & Research PDF